| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454492 | Lung Cancer | 2016 | 9 Pages |
Abstract
Our results thus demonstrate that the serum level of sMET is not indicative of the amount of MET present in the tumor cells and cannot be used as a biomarker for therapeutic purposes. However, MET scoring of tumor biopsies could be a first step prior to determination of MET receptor activation in high-MET tumors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marie-Christine Copin, Marie Lesaffre, Mélanie Berbon, Louis Doublet, Catherine Leroy, Emmanuelle Tresch, Henri Porte, Jérôme Vicogne, Alexis B. Cortot, Eric Dansin, David Tulasne,